Tighe Reardon

All filings by Tighe Reardon on record concern Janux Therapeutics, Inc., in the capacity of finance chief. We count 3 filings; the first trade dates from 15 June 2021 and the latest from 3 June 2024.

The open-market side counts 1 purchase for €4.7M alongside 1 sale for €6.6M. Taken together, the sales exceed the purchases by €1.9M. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. In 2024 alone, the filings show no purchases and 1 sale.

The record was last updated on 5 June 2024 with an open-market sale (€6.6M) in Janux Therapeutics, Inc. The last insider purchase was made public on 15 November 2023, 1,068 days ago. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.